PALISADE BIO, INC. (PALI) Operating cash flow 2016–2025
PALISADE BIO, INC. (PALI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.8MFY2025 · since FY2016: -$15.6M → -$10.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.8M | +11.0% |
| FY2024 | -$12.2M | -9.5% |
| FY2023 | -$11.1M | +16.7% |
| FY2022 | -$13.4M | +9.6% |
| FY2021 | -$14.8M | -209.8% |
| FY2020 | -$4.8M | +34.3% |
| FY2019 | -$7.3M | +5.7% |
| FY2018 | -$7.7M | +42.7% |
| FY2017 | -$13.4M | +14.1% |
| FY2016 | -$15.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PALI financial trends
PALI RevenuePALI Net incomePALI Net marginPALI Gross profitPALI Gross marginPALI Operating incomePALI Operating marginPALI Free cash flowPALI Capital expendituresPALI Return on equityPALI Stock buybacksPALI Dividends paidPALI Total assetsPALI Total liabilitiesPALI Shareholders’ equityPALI overview →